UFP Industries (UFPI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Dec, 2025Executive summary
Full-year 2024 net sales were $6.7 billion with adjusted EBITDA of $682.3 million and a 10.3% margin, reflecting a focus on value-added products and operational improvements.
Q4 2024 net sales were $1.46 billion, down 4% year-over-year, with sequentially declining demand and compressed operating profits.
Leadership executed cost and facility reductions, with $60 million in annual EBITDA improvements targeted by 2026 and ongoing project prioritization.
Strong liquidity maintained, with $1.17 billion in cash and $2.5 billion in total liquidity at year-end.
Leadership transition: Will Schwartz became CEO and president; Mike Cole expanded to president of corporate services.
Financial highlights
2024 net sales declined to $6.7 billion from $7.2 billion in 2023; adjusted EBITDA was $682.3 million (10.3% margin), down from $810 million (11.2%) in 2023.
Q4 adjusted EBITDA was $132.7 million (9.1% margin), down from $165.6 million (10.9%) last year.
Operating cash flow for 2024 was $642.6 million.
Return on invested capital for 2024 was 18.3%, exceeding the 15% hurdle rate.
Dividend increased 6% to $0.35 per share quarterly.
Outlook and guidance
Softer demand and competitive pricing expected to persist through H1 2025 across all segments.
Long-term goals: 7–10% annual unit sales growth (including acquisitions), 12.5% adjusted EBITDA margin, and net debt/EBITDA below 1.5x.
$60 million in annual EBITDA improvements from cost and capacity reductions targeted by 2026.
2025 CapEx plan is $350 million, with continued focus on acquisitions and innovation.
SG&A for 2025 (excluding variable incentives) targeted at $565 million, flat year-over-year.
Latest events from UFP Industries
- Annual meeting to vote on directors, auditor, and executive pay, with strong ESG focus.UFPI
Proxy Filing9 Mar 2026 - Votes will be cast for four directors, auditor ratification, and executive pay approval.UFPI
Proxy Filing9 Mar 2026 - 2025 sales fell but margin gains, cash flow, and cost cuts support growth plans for 2026.UFPI
Q4 202524 Feb 2026 - Q2 sales and profits declined, but strong liquidity and capital returns support long-term growth.UFPI
Q2 20242 Feb 2026 - Q3 sales and earnings declined, but liquidity, cost cuts, and capital returns remain strong.UFPI
Q3 202418 Jan 2026 - Q1 2025 sales and margins declined, but liquidity and capital returns remain strong.UFPI
Q1 202524 Dec 2025 - Director elections, auditor ratification, and performance-based executive pay headline the agenda.UFPI
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay are up for vote at the 2025 meeting.UFPI
Proxy Filing1 Dec 2025 - Q3 2025 sales and earnings declined, but liquidity and capital returns remain strong.UFPI
Q3 20255 Nov 2025